Bladder Cancer
Prostate Cancer
EAU Edu Platform on Kidney Cancer
Home
Articles
Article of the Month
Editorials
Videos
Webcasts
Education
E-courses
Webinars
Online curriculum
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorials
Videos
Webcasts
Education
Terug
E-courses
Webinars
Online curriculum
Guidelines
Events
Upcoming event
40th Annual EAU Congress
Home
/
Videos
Back
UROonco24
EAU24
EAU23
ASCO GU23
ESMO2022
EAU22
ASCO22
ASCO GU22
EAU 21
EAU20
ESOU Online
EAU19
GU19
EMUC 2018
EMUC 2014
ESMO 2014
ERUS 2014
Filter
Tags
Article of the Month
,
ASCO GU22
,
ASCO21
,
AUA21
,
Cabozantinib
,
Carcinoma
,
Chronic kidney disease
,
Cryosurgery
,
EAU
,
EAU21
,
EAU22
,
EMUC21
,
EMUC22
,
ERUS22
,
ESMO21
,
Frail patient
,
Glomerular filtration rate
,
Guidelines
,
IMDC risk model
,
Kidney cancer
,
Laparoscopy
,
Lymph node metastases
,
Lymph nodes
,
Metastasectomy
,
Mortality
,
Neoplasm metastasis
,
Neoplasm recurrence
,
Nephrectomy
,
Nephron-sparing surgery
,
Nivolumab
,
Overall survival
,
Partial nephrectomy
,
Prognostication
,
Radical nephrectomy
,
Radical surgery
,
RCC
,
Renal cancer
,
Renal cell
,
Renal cell carcinoma
,
Renal Cell Carcinoma guidelines
,
Renal cryoablation
,
Renal function
,
Renal Transplantation
,
Renorrhaphy
,
Robotic
,
Robotic prostatectomy
,
Robotic surgery
,
Survival outcome
,
Suture
,
Targeted therapies
,
Treatment response
,
Urological surgery
,
UROonco24
,
UROwebinar
,
Webinar
Show all
UROwebinar management of metastatic kidney cancer
Watch now
Cohort 1 of LITESPARK-003
Watch now
Patient engagement is a potential blockbuster treatment that urologists should prescribe for their cancer patients
Watch now
Updated results from the 30-month follow-up of KEYNOTE-564
Watch now
New surgical development in renal cancer surgery
Watch now
Variation in recurrence rate and overall survival (OS) outcomes by disease stage and incremental impact of time to recurrence on OS in localized renal cell carcinoma (RCC)
Watch now
The relationship between health-related quality of life (HRQoL) and clinical outcomes in patients with advanced renal cell carcinoma (aRCC) in CheckMate (CM) 214
Watch now
CYTOSHRINK study
Watch now
Should cure be a reasonable goal in aRCC?
Watch now
Immunotherapy-based management of metastatic clear-cell and variant RCC: What can we achieve?
Watch now
KEYNOTE-564 study
Watch now
Indocyanine green guidance during 3D augmented reality robot assisted partial nephrectomy: A step towards the “automatic” overlapping
Watch now
Previous
Next